- Home
- EAST vs CYTO Comparison
EAST vs CYTO Comparison
Compare EAST & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAST
- CYTO
- Stock Information
- Founded
- EAST 2008
- CYTO 2003
- Country
- EAST United States
- CYTO Bermuda
- Employees
- EAST N/A
- CYTO N/A
- Industry
- EAST Beverages (Production/Distribution)
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- EAST Consumer Staples
- CYTO Health Care
- Exchange
- EAST Nasdaq
- CYTO Nasdaq
- Market Cap
- EAST 2.2M
- CYTO 2.2M
- IPO Year
- EAST N/A
- CYTO N/A
- Fundamental
- Price
- EAST $0.44
- CYTO $0.46
- Analyst Decision
- EAST Strong Buy
- CYTO
- Analyst Count
- EAST 1
- CYTO 0
- Target Price
- EAST $3.50
- CYTO N/A
- AVG Volume (30 Days)
- EAST 81.6K
- CYTO 106.0K
- Earning Date
- EAST 11-14-2024
- CYTO 09-24-2024
- Dividend Yield
- EAST N/A
- CYTO N/A
- EPS Growth
- EAST N/A
- CYTO N/A
- EPS
- EAST N/A
- CYTO N/A
- Revenue
- EAST $9,537,000.00
- CYTO N/A
- Revenue This Year
- EAST $19.61
- CYTO N/A
- Revenue Next Year
- EAST $73.48
- CYTO N/A
- P/E Ratio
- EAST N/A
- CYTO N/A
- Revenue Growth
- EAST 81.73
- CYTO N/A
- 52 Week Low
- EAST $0.44
- CYTO $0.40
- 52 Week High
- EAST $2.98
- CYTO $17.20
- Technical
- Relative Strength Index (RSI)
- EAST 34.80
- CYTO 35.77
- Support Level
- EAST $0.51
- CYTO $0.40
- Resistance Level
- EAST $0.60
- CYTO $0.62
- Average True Range (ATR)
- EAST 0.06
- CYTO 0.05
- MACD
- EAST -0.01
- CYTO 0.00
- Stochastic Oscillator
- EAST 15.51
- CYTO 26.23
About EAST Eastside Distilling Inc.
Eastside Distilling Inc is a producer and marketer of Craft Canning and Printing and Spirits. Its alcoholic beverage categories include whiskey, vodka, gin, rum, tequila, and Ready-to-Drink. Some of its brands include Azunia Tequila, Hue-Hue Coffee Rum, Portland Potato Vodka, and Burnside Whiskey. It operates in two segments of packaging, producing, marketing, and distributing alcoholic beverages. Craft Canning + Printing includes Digital Can Printing, Co-packing Facility, and Mobile Canning. The company distributes its products in 33 states of the United States.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.